Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
Sponsor: Pfizer
Summary
The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is high blood pressure in the arteries that carry blood from the heart to the lungs. This high pressure makes it harder for the heart to pump blood through those lungs, potentially damaging the right side of the heart. This is an open-label study. Which means that both the healthcare providers and the study participants are aware of the medicine being given. This study is also an extension study with study medicine (PF-07868489). An extension study allows patients from an earlier clinical study (also called as qualifying study) to continue participating to assess long-term benefits and safety of the medicine.
Official title: A PHASE 2, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF PF-07868489 ADMINISTERED TO ADULT PARTICIPANTS WITH PULMONARY ARTERIAL HYPERTENSION
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2025-11-10
Completion Date
2028-08-24
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
PF-07868489
Participants will receive subcutaneous doses of PF-07868489 every 4 weeks
Locations (27)
UCSF Health St. Mary's Hospital
San Francisco, California, United States
Heart and Vascular Center
San Francisco, California, United States
UCSF Helen Diller Medical Center at Parnassus Heights
San Francisco, California, United States
Mount Sinai Hospital
New York, New York, United States
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Pulmonary Hypertension Research Queensland Pty Ltd
Auchenflower, Queensland, Australia
HUB Hôpital Erasme
Brussels, Belgium
UZ Leuven
Leuven, Belgium
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
Thoraxklinik-Heidelberg gGmbH
Heidelberg, Baden-Wurttemberg, Germany
Universitätsklinikum Regensburg
Regensburg, Bavaria, Germany
Universitaetsklinikum Giessen und Marburg GmbH
Giessen, Hesse, Germany
Universitätsmedizin Greifswald
Greifswald, Mecklenburg-Vorpommern, Germany
Universitaetsklinikum Carl Gustav Carus, Technischen Universitaet Dresden
Dresden, Saxony, Germany
Kobe University Hospital
Kobe, Hyōgo, Japan
St. Marianna University Hospital
Kawasaki, Kanagawa, Japan
National Hospital Organization Okayama Medical Center
Okayama, Japan
Gachon University Gil Medical Center
Incheon, Incheon-gwangyeoksi [incheon], South Korea
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Severance Hospital, Yonsei University Health System
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Hospital Universitario 12 de Octubre
Madrid, Spain
Hammersmith Hospital
London, Greater London, United Kingdom